Changes induced by KI administration on plasma heparinic activity in healthy subjects.
Other researches WE HAVE carried out show how it is possible to correct the high level of neutral fats in subjects with high trygliceridemia, with the administration of KI. We wished to ascertain whether the capacity of KI to reduce trygliceridemia when this is increased should be correlated to a possible change induced by this salt on PHA. Our researches has been carried out on 11 subjects who received a daily dose of 28 mg/Kg of b.w. of KI for a period of 10 days. The result we have obtained indicates that the administration of KI does not cause any significant change of PHA both after load and after prolonged treatment with KI.
D006493:Heparin / Q000097:blood*; D006801:Humans; D011193:Potassium Iodide / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood*
D014280:Triglycerides; D011193:Potassium Iodide; D006493:Heparin